CRC Press eBooks
Cure8 research brief
Why This Matters
People with IBD often look for safe complementary therapies. Preclinical studies of mangrove extracts suggest possible anti-inflammatory and gut-protective effects worth further research, but they are not proven treatments.
Who Should Pay Attention
Adults with IBD interested in complementary therapies, researchers studying natural products or novel anti-inflammatory compounds, and clinicians tracking emerging preclinical research.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The chapter reports animal-model studies suggesting certain mangrove extracts can reduce inflammation, oxidative stress, and tissue damage relevant to IBD, and discusses possible immune- and barrier-related mechanisms.
These findings are preclinical and exploratory: the chapter notes that more research is needed to define mechanisms, safety, dosing, and whether effects translate to humans.
If you are interested in complementary or natural-product research, this chapter provides mechanistic background and points to experimental evidence but does not present clinical trial data or treatment recommendations.
Keep In Mind
This is an academic book chapter summarizing mainly animal-model and preclinical work; it does not provide clinical trial evidence. The chapter itself emphasizes the need for more extensive research to determine mechanisms, dosing, safety, and human efficacy.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationCRC Press eBooks
AuthorsGandham Sandeep Kumar, Payani Sholapuri, G.V. Swarnalatha +1 more
Study typeBook Chapter
Indexed viaOpenAlex
Source typeResearch paper
PublishedOct 7, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The Therapeutic Potential of Berry-Derived and Berry-Based Interventions in Inflammatory Bowel Disease: A Comprehensive Systematic Review of Preclinical and Clinical Evidence
Berries are a familiar, dietary source of anti-inflammatory bioactive compounds that might help reduce intestinal inflammation and improve biomarkers relevant to IBD. Patients often seek safe, complementary strategies...
Vitamin D and Intestinal Diseases: Impact on Intestinal Immunity and Gut Barrier Function
Vitamin D appears linked to immune regulation, gut barrier health, and the microbiome—processes relevant to IBD and other intestinal disorders. Understanding this could affect how clinicians monitor and study vitamin D...
Vitamin D in mucosal healing: therapeutic potential and current evidence in inflammatory bowel disease
Vitamin D may support intestinal barrier integrity and immune regulation—pathways central to mucosal healing and disease control in IBD. Understanding the evidence helps patients and clinicians consider vitamin D as a...